Addressing obesity with KD Obesity is a growing but often neglected public health issue around the world, despite dietary guidelines and recommendations
Orforglipron received FDA approval as brand-name Foundayo in early April 2026
Demand for these medicines is rising as they are increasingly used to help patients that have acquired immune deficiencies, such as those being treated for cancer
| supplementation led to a significant increase in 13C-fat oxidation whereas protein synthesis and breakdown rates remained unchanged, indicating that the increased dietary fat oxidation in slightly overweight subjects was not accompanied by protein catabolism
Supplementation should be guided by lab testing to correct deficiency safely
Given that species which have GS-like genes from the first expansion (Clade 2) have retained the progenitor housekeeping gene (Clade 1), and those that have GS-like genes from the second expansion (Clade 3) have retained both Clade 1 and 2, this suggests that the role of each expansion does not supersede its predecessor(s)